InBodyLtd Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Ki-Chul Cha
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 29.9yrs |
| CEO ownership | 20.2% |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
Recent updates
There's No Escaping InBody Co.,Ltd's (KOSDAQ:041830) Muted Earnings
Nov 12
Be Wary Of InBodyLtd (KOSDAQ:041830) And Its Returns On Capital
Aug 12InBodyLtd (KOSDAQ:041830) Could Be Struggling To Allocate Capital
Apr 12Why Dividend Hunters Love InBody Co.,Ltd (KOSDAQ:041830)
Mar 25Can InBody Co.,Ltd (KOSDAQ:041830) Performance Keep Up Given Its Mixed Bag Of Fundamentals?
Mar 08Do Insiders Own Lots Of Shares In InBody Co.,Ltd (KOSDAQ:041830)?
Feb 18
How Much Did InBodyLtd's(KOSDAQ:041830) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jan 31Has InBodyLtd (KOSDAQ:041830) Got What It Takes To Become A Multi-Bagger?
Jan 11InBody Co., Ltd. (KOSDAQ:041830) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Dec 24Why Dividend Hunters Love InBody Co., Ltd. (KOSDAQ:041830)
Dec 17InBody Co., Ltd.'s (KOSDAQ:041830) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Dec 02Do Institutions Own InBody Co., Ltd. (KOSDAQ:041830) Shares?
Nov 17CEO
Ki-Chul Cha (66 yo)
29.9yrs
Tenure
Dr. Cha Ki-Chul has been the Chief Executive Officer of InBody Co.,Ltd (formerly known as Biospace Co., Ltd.) since 1995 and also serves as its Director. Dr. Cha served as an Assistant Manager of Daelim R&...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 16:27 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
InBody Co.,Ltd is covered by 17 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kathy Park | CGS International |
| null null | DBS Bank Ltd |
| Jaesong Woo | Haitong International Research Limited |